SAMN33843062
External Id
dbGaP
INSDC center name
2023-03-21T12:19:33.467Z
INSDC first public
2023-07-14T03:18:40.270Z
INSDC last update
SRS17620095
INSDC secondary accession
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
SRS17620095
SRA accession
DNA
analyte type
NCI_PALTAN
biospecimen repository
D1529467
biospecimen repository sample id
breast
body site
phs003147
gap_accession
1
gap_consent_code
GRU-PUB
gap_consent_short_name
5344728
gap_sample_id
4420257
gap_subject_id
Yes
is tumor
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
female
sex
Clinical Trial
study design
A Phase II Neoadjuvant Study of Palbociclib in Combination with Letrozole and Trastuzumab as Neoadjuvant Treatment of Stage II-III ER+ HER2+ Breast Cancer (PALTAN)
study name
D1529467
submitted sample id
RPTAN004
submitted subject id
NCI_PALTAN
submitter handle
Tumor DNA sample from breast of a human female participant in the dbGaP study A Phase II Neoadjuvant Study of Palbociclib in Combination with Letrozole and Trastuzumab as Neoadjuvant Treatment of Stage II-III ER+ HER2+ Breast Cancer (PALTAN)
title